David S. Wichmann - 07 May 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Reporting relationship: Director
Issuer ticker: BSX
Reported as of: 07 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 May 2026, 16:33:18 UTC
Prior SEC filing: 23 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Susan Thompson, Attorney-in-Fact

Key filing fact

David S. Wichmann filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 11 May 2026.

Key facts

This page summarizes David S. Wichmann's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 May 2026, 16:33.

Change

Previous filing in this sequence was filed on 23 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001268489 Primary reporting owner

WICHMANN DAVID S

Relationship: Director
Address: 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH
Signature: /s/ Susan Thompson, Attorney-in-Fact
Signature date: 11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSX transaction

Common Stock

Award

Transaction value
Shares: +3,800
Change %: +9.1%
Price: $0.000000^*
Shares after: 45,382
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.